Invesco Biotechnology & Genome ETF

PBEAMEX · USD
95.13USD-0.54 (-0.57%)

Invesco Biotechnology & Genome ETF (PBE) Option Chain

As of September 17, 2026, Invesco Biotechnology & Genome ETF is trading at $95.13, a -0.57% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 22.1%. IV Rank is 11%.

Read more

Tracking the PBE option chain helps you see every strike and expiry on Invesco Biotechnology & Genome ETF in one view, so you can quickly identify the contracts that fit your thesis and your risk. Invesco Biotechnology & Genome ETF's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of PBE options activity at a glance. Use our scanner to monitor the PBE option chain in real time and filter for the PBE options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For PBE stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the PBE option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where PBE stock options are being actively traded and where they are not.

The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.

The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Invesco Biotechnology & Genome ETF's full chain across every expiry, highlights the most liquid strikes, and lets you screen PBE options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of PBE stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryExchange Traded Fund
  • SectorFinancial
  • IV percentile3.97% Subdued
  • Market cap (M$)
  • 52 weeks high-3.19%
  • 52 weeks low41.34%
  • Analyst recommendation
  • Target price
  • Dividend
  • Payout ratio
  • Earnings date
  • P/E
  • Future P/E
  • EPS (ttm)
  • EPS growth next 5 years

As of September 17, 2026

2026-09-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.0000-0.037.135.109.1088.00-8.022.050.002.0500100.00
0.0010-0.036.134.108.1089.00-6.972.050.002.0500100.00
0.0000-0.085.133.107.0090.00-5.932.050.002.0500100.00
22.71002.470.132.6095.00-0.702.400.002.400077.32
100.00002.050.002.05100.00+4.532.906.904.870.03000.00

As of September 17, 2026

Scan the full option chain in one place

Browse the full PBE option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial